I
mpact of linzagolix treatment on anemia in women with uterine fibroid related heavy menstrual bleeding: results of two
P
hase 3 clinical trials
Lead author: William Catherino, MD, PhD; Professor, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences
Key Conclusions: High and low linzagolix doses with and without ABT improved hemoglobin and ferritin levels in anemic women with uterine fibroids. In the 12-week follow-up period hemoglobin levels decreased but did not return to baseline levels.
Poster
:
Safety of linzagolix in the treatment of women with uterine fibroids: Results from two Phase 3 clinical trials
Lead author: Hugh Taylor, MD; Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine